Author:
Orlandi Cesare,Zimmer Christopher A.,Gheorghiade Mihai
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine,Emergency Medicine
Reference73 articles.
1. American Heart Association: Heart disease and stroke statistics: 2005 update. www.americanheart.org. Accessed July 13, 2005.
2. Gheorghiade M, Gattis WA, O’Connor CM, et al., and the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators: Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure. JAMA 2004, 291:1963–1971. First demonstration of efficacy of a vasopressin antagonist in a large population of heart failure patients. First suggestion that antagonism of vasopressin may affect outcomes.
3. Cuffe MS, Califf RM, Adams KF Jr, et al.: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002, 287:1541–1547.
4. Jong P, Vowinckel E, Liu PP, et al.: Prognosis and determinants of survival in patients newly hospitalized for heart failure. Arch Intern Med 2002, 162:1689–1694.
5. Publication Committee for the VMAC Investigators: Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. JAMA 2002, 287:1531–1540.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献